Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Clinical trial NCT07363460 · RECRUITING

Trial details

NCT number: NCT07363460
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis (LN)

Start date: 2025-11-18
Primary completion: 2027-11-05
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.